BeCRO will be present at the “BCF Career Event Belgium” on November 22, in Gent. During this event we will be looking for new talents. If you’re a student, a PHD or a Postdoc and you have a pharma, chemistry, biology or bio sciences background, do not hesitate to come and meet us at the […]Read More "BeCRO will be present at the BCF Career Event on Nov 22"
BeCRO has partaken to the Knowledge for Growth conference on May 17, 2018 10 of our members have shared a BeCRO booth on this 14th edition of the Knowledge for Growth conference in Ghent on May 17, 2018. It was a great success, with many visitors and top level conference talks. The […]Read More "BeCRO has partaken to the Knowledge for Growth conference on May 17, 2018"
SAVE THE DATES (members only !) Next CEO lunches: * March 30, 2018 before the General Assembly: CRO Merger & Acquisitions: Rohan Saikia : Managing Director at Great Point Partners, NY, USA Marc Kobylinski : Executive Director at Allyum, Belgium Jean-Luc Marsat : Partner at AEC Partner’s & Founder of Mars@Partners, France (former Managing Director SGS Clinical Research, […]Read More "CEO lunches"
GDPR, all CROs and entreprises are getting compliant The new EU regulation on General Data Protection is to be applied as of May 25, 2018. Read more here and make sure your CRO is compliant : GDPR regulationRead More "GDPR, all CROs and entreprises are getting compliant"
Surfing the innovation wave, an interview with the Director General EFPIA Influential industry body, EFPIA, has for years helped pharma improve transparency and repair its long-tainted reputation. Tackling key issues such as innovation, patient access and collaborative R&D, Eyeforpharma caught up with the new Director General, Nathalie Moll, to discover where their focus is for […]Read More "Surfing the innovation wave, an interview with the Director General EFPIA"
Direct to Patient (D2P) shipment for Clinical Trials – Survey Dear Sponsor, CRO, Investigator or Patient, Within Europe and more specifically within Belgium, Direct To Patient (D2P) shipments have limitations within the current regulatory framework. Considering the growing enthusiasm of pharma companies, investigators and patients performing D2P shipments in the US, we need to investigate […]Read More "Direct to Patient (D2P) shipment for Clinical Trials – Survey"
Virtual Clinical Trials and Direct to Patient Shipments BeCRO has set up and coordinates, with the cabinet of Maggie De Block, FAMHP, FlandersBio, BioWin, Lifetech Brussels, BRAS and several top Pharma companies, a lobbying group on “Virtual Clinical trials and Direct to Patient Shipments”. This working group has conducted a survey on Direct to Patient […]Read More "Virtual Clinical Trials and Direct to Patient Shipments"
BeCRO invited in Tokyo to promote Belgium as a gateway to clinical research in Europe Bruxelles Invest & Export invited BeCRo to present the attractivness of Brussels for clinical trials in the European Union, during the Brussels Days in Tokyo on May 18, 2016. This event was organized on the occasion of celebrating 150 years […]Read More "BeCRO invited in Tokyo to promote Belgium as a gateway to clinical research in Europe"
BeCRO co-organizer of a luncheon event, at BIO 2016 in San Francisco, introduced by Minister Maggie De Block Bio San Francisco on June 7, 2016 : BeCRO co-organized with Bruxelles Invest & Export a luncheon event, introduced by Belgian Federal Minister of Public Health and Social Affairs, Maggie De Block, to reinforce Belgium’s commitment […]Read More "BeCRO co-organizer of a luncheon event, at BIO 2016 in San Francisco"